Riley Griffin Bloomberg
- All
- News
-
Instagram Chief Says App Has Feared TikTok Threat for Years
As Instagram has evolved to compete with TikTok with more video entertainment, so has the reason people come to the platform, platform’s chief Adam Mosseri told a federal court in Washington during the US antitrust trial against Meta. Only one in six posts to Instagram’s Stories feature are now from people engaging with their friends and family...
-
Meta Faces FTC Trial With Instagram, WhatsApp Breakup at Risk
The US Federal Trade Commission is targeting Meta's deals for Instagram and WhatsApp in a landmark antitrust lawsuit set to go to trial Monday, alleging that the acquisitions were illegal, should never have been approved and should be broken up.
-
Meta Whistleblower to Tell Congress That Company Aided China in AI Race
Sarah Wynn-Williams who served as director of global public policy at Meta, will tell the Senate Judiciary Subcommittee on Crime and Counterterrorism on Wednesday that she witnessed executives undermining US national security. The testimony will include allegations that Meta, formerly called Facebook, helped China advance in the artificial intellig...
-
Meta Starts Eliminating Jobs in Shift to Find AI Talent
Meta has started notifying “low-performers” that they are being laid off. The company is scouring for new talent to dominate the AI race. The company is offering US-based employees severance packages that include 16 weeks of salary, in addition two weeks for each year of service.
-
Meta to Cut Roughly Five Percent of Staff, Targeting Lowest Performers
Meta Platforms Inc. is cutting roughly five percent of its staff through performance-based terminations. Affected workers in the US are expected to be notified on February 10, while those based in other countries will be informed at a later date, according to the memo.
-
Strong Evidence That Covid Jumped From Animals To Humans, Claims Report
A new analysis of samples taken from a market in Wuhan, China during the early days of the pandemic are the strongest evidence yet that the Covid-19 virus jumped from animals to humans, some researchers say.
-
Johnson & Johnson Drops Talcum Powder Globally As Lawsuits Mount
Johnson & Johnson said it plans to stop selling its legacy talc-based baby-powder products globally in 2023, a move that comes amid continued legal battles and years after the company discontinued the product in the US and Canada.
-
Omicron Problem For Doctors: How To Know What To Prescribe
The omicron variant presents a new problem for doctors: Some drugs may work better than others, but knowing what to prescribe will hinge on quickly figuring out what variant of Covid-19 a person has in the first place.
-
'No Zoom' Plan For Top Health Meet Backfires As Heavyweights Pull Out
Few of the corporate world's most prominent leaders have been as effusive this year as Jamie Dimon in cajoling office workers back into pre-pandemic routines, arguing his army of bankers at JPMorgan & Chase & Co. can't tend relationships nearly as we
-
Omicron Scare: Pfizer Says Third Dose Key To Fight Spread
Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-spec
-
J&J's Covid Shot Gets US Regulator Warning About Rare Immune Disorder
The fact sheet for Johnson & Johnson's Covid-19 vaccine was revised to warn of the risk of a rare immune-system disorder, adding new headwinds for a shot once expected to be a linchpin of the US immunization effort.
-
J&J Says Its Vaccine Gives At Least 8-Month Immunity For Delta Variant
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly.
-
J&J Pause Over Blood-Clots To Educate Doctors, Study Cases: US Regulator
U.S. health officials urged a pause on the use of Johnson & Johnson's Covid-19 vaccine due to dangerous blood-clotting to give them time to educate doctors on how to treat the exceedingly rare disorder.
-
J&J Vaccine Manufacturing Error Affects 15 Million Doses: Report
A manufacturing error at a plant involved in Covid-19 vaccine production affected 15 million doses worth of an ingredient for Johnson & Johnson's vaccine, according to two people familiar with the matter, though the company downplayed the situation a
-
US Giant Merck Ends Covid Vaccine After Poor Response
Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.
-
Instagram Chief Says App Has Feared TikTok Threat for Years
As Instagram has evolved to compete with TikTok with more video entertainment, so has the reason people come to the platform, platform’s chief Adam Mosseri told a federal court in Washington during the US antitrust trial against Meta. Only one in six posts to Instagram’s Stories feature are now from people engaging with their friends and family...
-
Meta Faces FTC Trial With Instagram, WhatsApp Breakup at Risk
The US Federal Trade Commission is targeting Meta's deals for Instagram and WhatsApp in a landmark antitrust lawsuit set to go to trial Monday, alleging that the acquisitions were illegal, should never have been approved and should be broken up.
-
Meta Whistleblower to Tell Congress That Company Aided China in AI Race
Sarah Wynn-Williams who served as director of global public policy at Meta, will tell the Senate Judiciary Subcommittee on Crime and Counterterrorism on Wednesday that she witnessed executives undermining US national security. The testimony will include allegations that Meta, formerly called Facebook, helped China advance in the artificial intellig...
-
Meta Starts Eliminating Jobs in Shift to Find AI Talent
Meta has started notifying “low-performers” that they are being laid off. The company is scouring for new talent to dominate the AI race. The company is offering US-based employees severance packages that include 16 weeks of salary, in addition two weeks for each year of service.
-
Meta to Cut Roughly Five Percent of Staff, Targeting Lowest Performers
Meta Platforms Inc. is cutting roughly five percent of its staff through performance-based terminations. Affected workers in the US are expected to be notified on February 10, while those based in other countries will be informed at a later date, according to the memo.
-
Strong Evidence That Covid Jumped From Animals To Humans, Claims Report
A new analysis of samples taken from a market in Wuhan, China during the early days of the pandemic are the strongest evidence yet that the Covid-19 virus jumped from animals to humans, some researchers say.
-
Johnson & Johnson Drops Talcum Powder Globally As Lawsuits Mount
Johnson & Johnson said it plans to stop selling its legacy talc-based baby-powder products globally in 2023, a move that comes amid continued legal battles and years after the company discontinued the product in the US and Canada.
-
Omicron Problem For Doctors: How To Know What To Prescribe
The omicron variant presents a new problem for doctors: Some drugs may work better than others, but knowing what to prescribe will hinge on quickly figuring out what variant of Covid-19 a person has in the first place.
-
'No Zoom' Plan For Top Health Meet Backfires As Heavyweights Pull Out
Few of the corporate world's most prominent leaders have been as effusive this year as Jamie Dimon in cajoling office workers back into pre-pandemic routines, arguing his army of bankers at JPMorgan & Chase & Co. can't tend relationships nearly as we
-
Omicron Scare: Pfizer Says Third Dose Key To Fight Spread
Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-spec
-
J&J's Covid Shot Gets US Regulator Warning About Rare Immune Disorder
The fact sheet for Johnson & Johnson's Covid-19 vaccine was revised to warn of the risk of a rare immune-system disorder, adding new headwinds for a shot once expected to be a linchpin of the US immunization effort.
-
J&J Says Its Vaccine Gives At Least 8-Month Immunity For Delta Variant
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly.
-
J&J Pause Over Blood-Clots To Educate Doctors, Study Cases: US Regulator
U.S. health officials urged a pause on the use of Johnson & Johnson's Covid-19 vaccine due to dangerous blood-clotting to give them time to educate doctors on how to treat the exceedingly rare disorder.
-
J&J Vaccine Manufacturing Error Affects 15 Million Doses: Report
A manufacturing error at a plant involved in Covid-19 vaccine production affected 15 million doses worth of an ingredient for Johnson & Johnson's vaccine, according to two people familiar with the matter, though the company downplayed the situation a
-
US Giant Merck Ends Covid Vaccine After Poor Response
Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.
